Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Kennedy

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Med (New York, N.Y.)|January 24, 2022
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipientsNicholas Kim Huat Khoo, Joey Ming Er Lim, Upkar S Gill, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2018
Molecular Recalibration of PD-1+ Antigen-Specific T Cells from Blood and LiverItziar Otano, David Escors, Anna Schurich, et al.
The Journal of Experimental Medicine|May 21, 2017
IL-2<sup>high</sup> tissue-resident T cells in the human liver: Sentinels for hepatotropic infectionLaura J Pallett, Jessica Davies, Emily J Colbeck, et al.
Journal of Hepatology|June 23, 2025
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phasesNina Le Bert, Apostolos Koffas, Rajneesh Kumar, et al.
Gastroenterology|April 18, 2020
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infectionNina Le Bert, Upkar S Gill, Michelle Hong, et al.
Hepatology (Baltimore, Md.)|April 30, 2024
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responsesBo Sun, Kelly A S da Costa, Aljawharah Alrubayyi, et al.
Biomedicines|October 23, 2021
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV ReactivationLorenzo Piermatteo, Mohammad Alkhatib, Stefano D'Anna, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infectionJay Preechanukul, Aljawharah Alrubayyi, Bo Sun, et al.
Gut|December 4, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infectionAnucha Preechanukul, Aljawharah Alrubayyi, Bo Sun, et al.
Gut|September 22, 2021
The human liver microenvironment shapes the homing and function of CD4<sup>+</sup> T-cell populationsBenjamin G Wiggins, Laura J Pallett, Xiaoyan Li, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Med (New York, N.Y.)|January 24, 2022
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipientsNicholas Kim Huat Khoo, Joey Ming Er Lim, Upkar S Gill, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2018
Molecular Recalibration of PD-1+ Antigen-Specific T Cells from Blood and LiverItziar Otano, David Escors, Anna Schurich, et al.
The Journal of Experimental Medicine|May 21, 2017
IL-2<sup>high</sup> tissue-resident T cells in the human liver: Sentinels for hepatotropic infectionLaura J Pallett, Jessica Davies, Emily J Colbeck, et al.
Journal of Hepatology|June 23, 2025
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phasesNina Le Bert, Apostolos Koffas, Rajneesh Kumar, et al.
Gastroenterology|April 18, 2020
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infectionNina Le Bert, Upkar S Gill, Michelle Hong, et al.
Hepatology (Baltimore, Md.)|April 30, 2024
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responsesBo Sun, Kelly A S da Costa, Aljawharah Alrubayyi, et al.
Biomedicines|October 23, 2021
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV ReactivationLorenzo Piermatteo, Mohammad Alkhatib, Stefano D'Anna, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infectionJay Preechanukul, Aljawharah Alrubayyi, Bo Sun, et al.
Gut|December 4, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infectionAnucha Preechanukul, Aljawharah Alrubayyi, Bo Sun, et al.
Gut|September 22, 2021
The human liver microenvironment shapes the homing and function of CD4<sup>+</sup> T-cell populationsBenjamin G Wiggins, Laura J Pallett, Xiaoyan Li, et al.
Pageof 8